Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Jan 5, 2021 20:00 UTC |
Walker Kathryn ADirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 318.161 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000004 · primary_doc.xml · derivative · entry 4 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 318.161 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 20:00 UTC |
Walker Kathryn ADirector
|
GrantCommon Stock | 6,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000004 · primary_doc.xml · nonDerivative · entry 3 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,386 F2 · security: Represents restricted stock award grant that vests in full on the first anniversary of the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 20:00 UTC |
Walker Kathryn ADirector
|
Disposition to issuerCommon Stock | 0.161 | $14.77 | $2.38 |
DisclosureSEC source: 0000926282-21-000004 · primary_doc.xml · nonDerivative · entry 2 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,292 F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 20:00 UTC |
Walker Kathryn ADirector
|
Exercise / conversionCommon Stock | 318.161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000926282-21-000004 · primary_doc.xml · nonDerivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,292.161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:43 UTC |
Nair BalanDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 318.161 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000003 · primary_doc.xml · derivative · entry 4 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 318.161 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:43 UTC |
Nair BalanDirector
|
GrantCommon Stock | 6,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000003 · primary_doc.xml · nonDerivative · entry 3 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,323 F2 · security: Represents restricted stock award grant that vests in full on the first anniversary of the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:43 UTC |
Nair BalanDirector
|
Disposition to issuerCommon Stock | 0.161 | $14.77 | $2.38 |
DisclosureSEC source: 0000926282-21-000003 · primary_doc.xml · nonDerivative · entry 2 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,229 F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:43 UTC |
Nair BalanDirector
|
Exercise / conversionCommon Stock | 318.161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000926282-21-000003 · primary_doc.xml · nonDerivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,229.161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:21 UTC |
HUSS H FENWICKDirector
|
Exercise / conversionDividend Equivalent Rights · Derivative | 318.161 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000002 · primary_doc.xml · derivative · entry 4 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 318.161 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:21 UTC |
HUSS H FENWICKDirector
|
GrantCommon Stock | 6,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000002 · primary_doc.xml · nonDerivative · entry 3 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,323 F2 · security: Represents restricted stock award grant that vests in full on the first anniversary of the date of grant. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:21 UTC |
HUSS H FENWICKDirector
|
Disposition to issuerCommon Stock | 0.161 | $14.77 | $2.38 |
DisclosureSEC source: 0000926282-21-000002 · primary_doc.xml · nonDerivative · entry 2 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,229 F1 · security: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 19:21 UTC |
HUSS H FENWICKDirector
|
Exercise / conversionCommon Stock | 318.161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000926282-21-000002 · primary_doc.xml · nonDerivative · entry 1 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,229.161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of dividend equivalent rights in connection with lapse of restriction on restricted stock. The rights accrued when and as dividends were paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 10:38 UTC |
NICHOLS ROY JDirector
|
GrantDividend Equivalent Rights · Derivative | 64.783 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000040 · primary_doc.xml · derivative · entry 1 NICHOLS ROY J · CIK 0000937725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318.161 Underlying: Common Stock · 64.783 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:18 UTC Amendment |
Foliano MichaelChief Financial Officer
|
GrantPhantom Stock · Derivative | 120.597 | $12.96 | $1,562.94 |
DisclosureSEC source: 0000926282-20-000052 · primary_doc.xml · derivative · entry 5 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,538.946 Underlying: Common Stock · 120.597 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:18 UTC Amendment |
Foliano MichaelChief Financial Officer
|
GrantCommon Stock | 1.635 | $11.76 | $19.23 |
DisclosureSEC source: 0000926282-20-000052 · primary_doc.xml · nonDerivative · entry 3 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 241.443 F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:18 UTC Amendment |
Foliano MichaelChief Financial Officer
|
GrantCommon Stock | 20.63 | $12.71 | $262.21 |
DisclosureSEC source: 0000926282-20-000052 · primary_doc.xml · nonDerivative · entry 2 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,164.63 F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:55 UTC Amendment |
Wilson James Denson JrChief Revenue Officer
|
GrantPhantom Stock · Derivative | 115.368 | $12.96 | $1,495.17 |
DisclosureSEC source: 0000926282-20-000051 · primary_doc.xml · derivative · entry 6 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,729.578 Underlying: Common Stock · 115.368 shares Expires not disclosed F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:55 UTC Amendment |
Wilson James Denson JrChief Revenue Officer
|
GrantCommon Stock | 27.139 | $12.96 | $351.72 |
DisclosureSEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 4 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 4,009.26 F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:55 UTC Amendment |
Wilson James Denson JrChief Revenue Officer
|
GrantCommon Stock | 26.9 | $12.71 | $341.90 |
DisclosureSEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 3 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,049 F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:13 UTC |
Scheiterer EduardSVP, Research & Development
|
GrantCommon Stock | 19.13 | $12.71 | $243.14 |
DisclosureSEC source: 0000926282-20-000050 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,597.13 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:07 UTC |
Harris RayChief Information Officer
|
GrantCommon Stock | 2.367 | $12.85 | $30.42 |
DisclosureSEC source: 0000926282-20-000049 · primary_doc.xml · nonDerivative · entry 1 Harris Ray · CIK 0001766181 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,479.464 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:01 UTC |
Centis RonaldSVP, Operations
|
GrantCommon Stock | 2.498 | $12.85 | $32.10 |
DisclosureSEC source: 0000926282-20-000048 · primary_doc.xml · nonDerivative · entry 1 Centis Ronald · CIK 0001769038 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,985.257 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:22 UTC Amendment |
STANTON THOMAS RDirector · Chairman and CEO
|
GrantPhantom Stock · Derivative | 686.271 | $12.71 | $8,722.50 |
DisclosureSEC source: 0000926282-20-000047 · primary_doc.xml · derivative · entry 5 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,516.977 Underlying: Common Stock · 686.271 shares Expires not disclosed F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:22 UTC Amendment |
STANTON THOMAS RDirector · Chairman and CEO
|
GrantCommon Stock | 123.78 | $12.71 | $1,573.24 |
DisclosureSEC source: 0000926282-20-000047 · primary_doc.xml · nonDerivative · entry 3 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,213.78 F2 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:59 UTC |
McCray Gregory JamesDirector
|
GrantDividend Equivalent Rights · Derivative | 64.783 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000045 · primary_doc.xml · derivative · entry 2 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318.161 Underlying: Common Stock · 64.783 shares Expires not disclosed F2 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:59 UTC |
McCray Gregory JamesDirector
|
GrantCommon Stock | 52.78 | $12.71 | $670.83 |
DisclosureSEC source: 0000926282-20-000045 · primary_doc.xml · nonDerivative · entry 1 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,233.217 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:32 UTC |
Jacqueline Hourigan RiceDirector
|
GrantDividend Equivalent Rights · Derivative | 64.783 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000044 · primary_doc.xml · derivative · entry 1 Jacqueline Hourigan Rice · CIK 0001637150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318.161 Underlying: Common Stock · 64.783 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:15 UTC |
Walker Kathryn ADirector
|
GrantDividend Equivalent Rights · Derivative | 64.783 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000043 · primary_doc.xml · derivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318.161 Underlying: Common Stock · 64.783 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:07 UTC |
Nair BalanDirector
|
GrantDividend Equivalent Rights · Derivative | 64.783 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000042 · primary_doc.xml · derivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318.161 Underlying: Common Stock · 64.783 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 15:55 UTC |
HUSS H FENWICKDirector
|
GrantDividend Equivalent Rights · Derivative | 64.783 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000041 · primary_doc.xml · derivative · entry 1 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318.161 Underlying: Common Stock · 64,783 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock grant. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| December 01, 2020 Filed Sep 7, 2021 17:25 UTC |
Kimpe MarcSVP, Research & Development
|
GrantCommon Stock | 11.124 | $12.86 | $143.05 |
DisclosureSEC source: 0000926282-21-000038 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,725.624 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 22:24 UTC |
Harris RayChief Information Officer
|
Disposition to issuerCommon Stock | 2,270 | $12.39 | $28,130.07 |
DisclosureSEC source: 0000926282-20-000032 · primary_doc.xml · nonDerivative · entry 1 Harris Ray · CIK 0001766181 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,671 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:33 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantPhantom Stock · Derivative | 4,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000039 · primary_doc.xml · derivative · entry 2 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,639.21 Underlying: Common Stock · 4,025 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F4 · price: Upon vesting of performance shares awarded pursuant to a grant of November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan, the reporting person deferred the receipt of shares of the Company's common stock and received instead shares of phantom stock pursuant to the Company's deferred compensation plan. F3 · derivative.exercise_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F3 · derivative.expiration_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:33 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantCommon Stock | 10,816 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000039 · primary_doc.xml · nonDerivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,180 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:20 UTC |
STANTON THOMAS RDirector · Chairman and CEO
|
GrantPhantom Stock · Derivative | 18,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000038 · primary_doc.xml · derivative · entry 2 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,532.706 Underlying: Common Stock · 18,702 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock or the cash value thereof. F4 · price: Upon vesting of performance shares awarded pursuant to a grant of November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan, the reporting person deferred the receipt of shares of the Company's common stock and received instead shares of phantom stock pursuant to the Company's deferred compensation plan. F3 · derivative.exercise_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. F3 · derivative.expiration_date: The phantom stock becomes payable 6 months after the reporting person's separation of service with the Company. The reporting person may transfer his phantom stock account into an alternative investment at any time. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:20 UTC |
STANTON THOMAS RDirector · Chairman and CEO
|
GrantCommon Stock | 50,246 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000038 · primary_doc.xml · nonDerivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,683 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:42 UTC |
Scheiterer EduardSVP, Research & Development
|
GrantCommon Stock | 7,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000037 · primary_doc.xml · nonDerivative · entry 2 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,316 F2 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:42 UTC |
Scheiterer EduardSVP, Research & Development
|
GrantCommon Stock | 2,729 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000037 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,806 F1 · security: Represents vesting of performance shares awarded pursuant to a grant on November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:32 UTC |
Foliano MichaelChief Financial Officer
|
GrantCommon Stock | 14,345 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000036 · primary_doc.xml · nonDerivative · entry 2 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,040 F2 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:32 UTC |
Foliano MichaelChief Financial Officer
|
GrantCommon Stock | 3,051 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000036 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,695 F1 · security: Represents vesting of performance shares awarded pursuant to a grant on November 11, 2017 under the ADTRAN, Inc. 2015 Employee Stock Incentive Plan. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 23:35 UTC |
Kimpe MarcSVP, Research & Development
|
GrantCommon Stock | 7,153 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000035 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,697 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 23:21 UTC |
Centis RonaldSVP, Operations
|
GrantCommon Stock | 8,933 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000033 · primary_doc.xml · nonDerivative · entry 1 Centis Ronald · CIK 0001769038 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,982.76 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 23:29 UTC |
Harris RayChief Information Officer
|
GrantCommon Stock | 6,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000034 · primary_doc.xml · nonDerivative · entry 1 Harris Ray · CIK 0001766181 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,477.1 F1 · security: Represents a grant of restricted stock units that vest in four equal and annual installments beginning on the first anniversary date of the grant. Read SEC document |
| November 16, 2020 Filed Dec 4, 2020 00:18 UTC Amendment |
Foliano MichaelChief Financial Officer
|
GrantPhantom Stock · Derivative | 3,051 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000052 · primary_doc.xml · derivative · entry 4 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,418.349 Underlying: Common Stock · 3,051 shares Expires not disclosed F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F4 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. F4 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. Read SEC document |
| November 16, 2020 Filed Dec 4, 2020 00:18 UTC Amendment |
Foliano MichaelChief Financial Officer
|
GrantCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000052 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,144 F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · balance_after: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 3,051 shares of common stock on November 16, 2020, which shares should have been reported as the acquisition of shares of Phantom stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. Read SEC document |
| November 16, 2020 Filed Dec 3, 2020 23:55 UTC Amendment |
Wilson James Denson JrChief Revenue Officer
|
GrantPhantom Stock · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000051 · primary_doc.xml · derivative · entry 5 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,614.21 Underlying: Common Stock · 0 shares Expires not disclosed F1 · derivative.exercise_price: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · derivative.exercise_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · derivative.expiration_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · derivative.underlying_shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · balance_after: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. Read SEC document |
| November 16, 2020 Filed Dec 3, 2020 23:55 UTC Amendment |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 1,182 | $12.51 | $14,786.82 |
DisclosureSEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 2 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,023 Read SEC document |
| November 16, 2020 Filed Dec 3, 2020 23:55 UTC Amendment |
Wilson James Denson JrChief Revenue Officer
|
GrantCommon Stock | 4,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000051 · primary_doc.xml · nonDerivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,205 F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 4,025 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. Read SEC document |
| November 16, 2020 Filed Dec 3, 2020 21:22 UTC Amendment |
STANTON THOMAS RDirector · Chairman and CEO
|
GrantCommon Stock | 18,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000047 · primary_doc.xml · nonDerivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,385 F1 · security: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. Read SEC document |
| November 16, 2020 Filed Mar 8, 2021 22:30 UTC Amendment | GrantCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-21-000019 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,010.88 F1 · security: On December 3, 2020, the reporting person filed a Form 4 incorrectly reporting the amount of securities beneficially owned. This amendment shows the correct number of shares of common stock owned by the reporting person. F1 · balance_after: On December 3, 2020, the reporting person filed a Form 4 incorrectly reporting the amount of securities beneficially owned. This amendment shows the correct number of shares of common stock owned by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.